RTI Biologics Inc.
(RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, is highlighting two new allografts and introducing a public education website at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in San Francisco this week.
, a sterile, room temperature DBM implant that provides a contoured fit to bony defects;
Fresh-stored Osteochondral Humeral Head
, an allograft that enables surgeons to resurface osteochondral defects in a single procedure; and
, an informational website to educate patients and the general public about allograft tissue, will be showcased at the RTI Biologics exhibit at booth 4137 (Hall E) during the AAOS meeting at the Moscone Center.
BioAdapt™ DBM is a flexible demineralized bone matrix (DBM) solution with unique handling capabilities. Designed to maximize ease of use, BioAdapt is a sterile, room-temperature implant offered in five pre-shaped options to meet the bone grafting needs of trauma, reconstructive, spine and extremity surgeons. With foam-like properties, BioAdapt expands with hydration to adapt to the contours of the bony defect. This versatile implant offers flexible, yet cohesive handling characteristics, making it easy to shape or mold to fit various defects.
The BioAdapt carrier component is sterilized through the
BioCleanse® Tissue Sterilization Process
and the DBM component is sterilized through the
Cancelle® SP DBM Sterilization Process
, which was specifically designed to preserve protein activity. BioAdapt DBM is available exclusively from RTI Biologics. For more information or to speak with an RTI’s customer service representative please contact (800) 624-7238.
Fresh-stored Osteochondral (OC) Humeral Head
RTI Biologics’ Fresh-stored OC Humeral Head allograft enables surgeons to resurface osteochondral defects with mature hyaline cartilage and healthy subchondral bone in a single procedure. The Fresh-stored OC Humeral Head is cleansed, processed and preserved to maintain chondrocyte viability.